Department of Thoracic Surgery, Scientific Institute and University Vita-Salute Ospedale San Raffaele, Milan, Italy.
Department of Thoracic Surgery, Scientific Institute and University Vita-Salute Ospedale San Raffaele, Milan, Italy.
Ann Thorac Surg. 2022 Jan;113(1):324-336. doi: 10.1016/j.athoracsur.2020.09.064. Epub 2020 Dec 18.
Thoracic endometriosis syndrome (TES) is a rare disorder characterized by the presence of functional endometrial tissue within the chest cavity. Up to 80% of women with TES present with concomitant pelvic endometriosis. The diagnostic-curative path is defined by both thoracic surgeons and gynecologists, consistent with the manifestation of the disease. The aim of the study was to analyze the different approaches to generate an ideal diagnosis-treatment algorithm that can be shared by both specialties.
We searched PubMed and Scopus for studies that were completed by March 2019 and that included at least 8 patients with TES. Information on preoperative exams, surgical technique, postoperative management, and recurrence of disease was collected for meta-analysis.
Twenty-five studies including a total of 732 patients were eligible. Almost all of the patients underwent radiologic pelvis investigation (96%; confidence interval [CI], 87%-100%). Videothoracoscopy was the preferred surgical technique (84%; 95% CI, 66%-96%). Intraoperative evaluation revealed the presence of diaphragmatic anomalies in 84% of cases (95% CI, 73%-93%). The overall pooled prevalence of concomitant or staged laparoscopy was 52% (95% CI, 18%-85%). Postoperative hormone therapy was heterogeneous with a pooled prevalence of 61% (95% CI, 33%-86%; I = 95.6%; P < .01). Recurrence of symptoms was documented in 27% of patients (95% CI, 20%-34%; I = 54.7%; P < .01).
TES should be managed jointly by thoracic surgeons and gynecologists. Chest-abdomen magnetic resonance imaging seems to offer the most details for TES. Combined or staged videothoracoscopy and laparoscopy can provide adequate information to fine-tune proper surgical treatment and postoperative medical therapy.
胸子宫内膜异位症(TES)是一种罕见疾病,其特征是胸腔内存在功能性子宫内膜组织。高达 80%的 TES 患者同时患有盆腔子宫内膜异位症。诊断-治疗路径由胸外科医生和妇科医生共同定义,与疾病的表现一致。本研究的目的是分析不同的方法,以生成一个理想的诊断-治疗算法,可由两个专业共享。
我们在 PubMed 和 Scopus 上搜索了截至 2019 年 3 月完成的至少包含 8 例 TES 患者的研究。收集了术前检查、手术技术、术后管理和疾病复发的信息进行荟萃分析。
25 项研究共纳入 732 例患者,均符合条件。几乎所有患者均接受了骨盆影像学检查(96%;置信区间[CI],87%-100%)。胸腔镜检查是首选的手术技术(84%;95%CI,66%-96%)。术中评估显示 84%的病例存在膈肌异常(95%CI,73%-93%)。总体腹腔镜联合或分期手术的发生率为 52%(95%CI,18%-85%)。术后激素治疗存在异质性,总发生率为 61%(95%CI,33%-86%;I²=95.6%;P<.01)。有 27%的患者记录到症状复发(95%CI,20%-34%;I²=54.7%;P<.01)。
TES 应由胸外科医生和妇科医生共同管理。胸部-腹部磁共振成像似乎能为 TES 提供最详细的信息。联合或分期胸腔镜和腹腔镜检查可提供足够的信息,以精细调整适当的手术治疗和术后药物治疗。